.
Sign in | Register
Home | My Space | Post
 ashokshah47 - Follow | Private Message
389 replies  | 98 followers | 6 following
View profile
Post your View/Query
We take the quality of the messages posted on forum as seriously as our articles. Kindly follow our Code of Conduct and refrain from posting any abusive, promotional or gibberish content on forum.
Replies | Rated | Following | Addressed
Latest
2 days ago
Sherkhan report - aurobindo plans to launch around 50 products in the us in fy2021 and expects to sustain the launch momentum in to fy2022e as well. with the demand from the europe and emerging mark...
  ashokshah47
     
2 days ago
The expected commissioning of a 450mn dose vaccine capacity by end of june 2021 provides a new growth avenue for aurobindo....
  ashokshah47
2 days ago
Aurobindo revenue in last five yrs (fy16-fy20) has gone up from 14 to 23 thousand-cr. fy21 about to end with record revenue not less than 25 thousand-cr....
  ashokshah47
2 days ago
Apl has been growing consistently. this year expected to hit record revenue of more than 25,000 cr and eps higher than 55. target price 1100 with modest p/e of 20....
  ashokshah47
3 days ago
Dudeshi - remdesivir is low margin medicine to cure carona patients. because of carona spread, this is required in huge quantities. real profit will be in the vaccine, which is under trial....
  ashokshah47
3 days ago
Cadila and cipla are main producers of remdesivir, which is low margin product.. if and when zydus vaccine comes in the market, cadila will make money. it is still under trials and expected to take ...
  ashokshah47
3 days ago
Cadila hype is overdone. vaccine still under trials. the vaccine is likely to be released only by june 2021. so do not be in hurry to buy. book profit around 580-600....
  ashokshah47
3 days ago
Cadila vaccine - no application with the authorities for approval as vaccine is still under phase3 trials. expected by june 2021 only....
  ashokshah47
3 days ago
Jsl_3940 - apl has been growing consistently. this year expected to hit record revenue of more than 25,000 cr and eps higher than 55. target price 1100 with modest p/e of 20....
  ashokshah47
     
3 days ago
Look at aurobindo eps growth. very very consistent. eps in last five yrs has gone up from 35 to 48. fy21 expected to end with eps not less than 55....
  ashokshah47
1 | 2 | 3   Next »
view comment
Stock Boarder Message
Active Topics
index | CRUDEOIL | SpiceJet | COPPER | Indosolar
Explore all topics
Boarder of the Day
amateurinvestor (26412 messages | 2207 followers)
HOME
Moneycontrol Home
Font Size: S M L
Customer Support
© 2021 a Web18 Venture